3B Blackbio DX Ltd (3BBLACKBIO) — shareholding pattern, promoter holding, financials and share price

3B Blackbio DX Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as 3BBLACKBIO and on the BSE under scrip code 532067. Its ISIN is INE994E01018.

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products [1]

3B BlackBio DX Limited is an Indian biotech and diagnostics company focused on molecular diagnostics (TRUPCR PCR kits, enzymes and reagents), Next‑Gen Sequencing assays (TRUNGS), and rapid tests (TRURAPID), while retaining legacy agrochemical operations; the company recently acquired Coris BioConcept (Belgium) and operates manufacturing and R&D facilities recognized by DSIR and ISO standards.

Management reported consolidated nine‑months revenue of INR99.06 crore (including Coris) versus INR64.80 crore earlier, with 3B standalone growing around 11.8% year‑on‑year and management guiding consolidated revenue growth of 10%–15% for the full year, while exports are expected to outpace domestic growth at 15%–20% given strengthened European and other geographies.

Listed peers in Healthcare Service Provider: Suraksha Diagnostic Ltd, One Global Service Provider Ltd, Health X Platform Ltd, Gaudium IVF and Women Health Ltd, Chandan Healthcare Ltd, Vaidya Sane Ayurved Laboratories Ltd.